-+ 0.00%
-+ 0.00%
-+ 0.00%

LifeSci Capital Initiates Coverage On Zymeworks with Outperform Rating, Announces Price Target of $30

Benzinga·03/11/2025 12:32:49
Listen to the news
LifeSci Capital initiates coverage on Zymeworks (NASDAQ:ZYME) with a Outperform rating and announces Price Target of $30.